Syntimmune: Syntimmune to Present at Jefferies 2018 Global Healthcare Conference

Syntimmune Inc. a clinicalstage biotechnology company developing antibody therapeutics targeting FcRn today announced that President and Chief Executive Officer JeanPaul Kress M.D. will present at the Jefferies 2018 Global Hea...